You are on page 1of 1

Technical Report on TiGRT Brachy TPS

The software was sent for Clinical evaluation and testing at TMH, Mumbai. Based
on the 3 weeks use, this report is made. This report is purely on technical
aspects of the software and IS NOT on clinical/physics aspects.

General:

1. Printing feature After a few days of use, the software wouldnt generate
reports. When the software is sent out to evaluate clinically, its not a good
point to restrict features. If this was intended, then it should have been
clearly mentioned before the usage.
2. Inconsistent Behaviour 3 versions have been released in 3 weeks time,
all having some kind of issues. Ver36 stopped printing, Ver37 was
intended to solve the issue but hangs after dose calculation and Ver 38
introduced new issues of not importing CT images and decay calculation.
Initial tests that were carried out in Ver36 have to be carried out in full in
Ver38.
3. When a new version is released, it is supposed to clear away earlier
reported bugs and not introduce new ones. In order to test the software,
all features have to be repeated. This is time consuming. Please make
some consistency checks beforehand.

Specific Issues:

1. Decay calculations A plan prepared with an earlier activity, when opened


again, automatic decay calculations doesnt take place. Instead of the time
changes, the total dose changes. This is not acceptable.
2. Once a plan is made, its not possible to switch to other modes. An
optimized plan once made, cant be made to unoptimize or vice versa.
3. Dose points Dose prescription seems to work well when compared to
other TPS. However, arbitrary dose points deviate by more than 10%.
When dose prescription matches, the variation of dose points raises
certain concerns.

Plan Transfer Issues:

1. A plan is printed and verified with the screen results. However, when the
same is transferred to the control unit, following issues were observed:
a. Number of dwell positions are doubled.
b. Dwell times are different.
c. Channels numbers are arbitrary for some plans.
d. Optimized plans are not the same as seen in the prints.
e. Step sizes planned are different with certain step sizes.

Only after correcting the above issues, the software can be put to clinical
evaluation.

You might also like